Epstein-Barr virus, cytokines, and inflammation: A cocktail for the pathogenesis of Hodgkin's lymphoma?

Experimental Hematology

Volumn 34, Issue 4, 2006, Pages 399-406

  Khan, Gulfaraz ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CHRONIC INFLAMMATION; CLASSICAL HODGKIN LYMPHOMA; CLINICAL FEATURE; EPSTEIN BARR VIRUS; HUMAN; INFECTIOUS MONONUCLEOSIS; INFLAMMATORY INFILTRATE; LYMPHOCYTE DEPLETION HODGKIN LYMPHOMA; MIXED CELLULARITY HODGKIN LYMPHOMA; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; REVIEW; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CELL COMMUNICATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; CYTOKINES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; INFLAMMATION; NF-KAPPA B; REED-STERNBERG CELLS;

HUMAN HERPESVIRUS 4;

EID: 33645227964     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.11.008     Document Type: Review

References (100)

1. C. Nathan Points of control in inflammation Nature 420 2002 846 852
2. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
3. E. Shacter, and S.A. Weitzman Chronic inflammation and cancer Oncology 16 2002 217 226
4. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
5. R.A. Gupta, and R.N. Dubois Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nat Rev Cancer 1 2001 11 21
6. P.M. Choi, and M.P. Zelig Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention Gut 35 1994 950 954
7. M.J. Thun, M.M. Namboodiri, and C.W. Heath Jr. Aspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1991 1593 1596
8. S. Zha, V. Yegnasubramanian, W.G. Nelson, W.B. Isaacs, and A.M. De Marzo Cyclooxygenases in cancer: progress and perspective Cancer Lett 215 2004 1 20
9. E. Pikarsky, R.M. Porat, and I. Stein NF-κB functions as a tumour promoter in inflammation-associated cancer Nature 431 2004 461 466
10. F.R. Greten, L. Eckmann, and T.F. Greten IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 2004 285 296
11. H.L. Pahl Activators and target genes of Rel/NF-κB transcription factors Oncogene 18 1999 6853 6866
12. B.B. Aggarwal Nuclear factor-κB: the enemy within Cancer Cell 6 2004 203 208
13. F. Balkwill, and L.M. Coussens An inflammatory link Nature 431 2004 405 406
14. B.F. Skinnider, and T.W. Mak The role of cytokines in classical Hodgkin lymphoma Blood 99 2002 4283 4297
15. L. Yung, and D. Linch Hodgkin's lymphoma Lancet 36 2003 943 951
16. T. Marafioti, M. Hummel, and I. Anagnostopoulos Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells N Engl J Med 337 1997 453 458
17. T. Marafioti, M. Pozzobon, M.L. Hansmann, G. Delsol, S.A. Pileri, and D.Y. Mason Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease Blood 103 2004 188 193
18. E.S. Jaffe, P.M. Banks, B. Nathwani, J. Said, and S.H. Swerdlow Recommendations for the reporting of lymphoid neoplasms: A report from the Association of Directors of Anatomic and Surgical Pathology Mod Pathol 17 2004 131 135
19. C.A. Iacobuzio-Donahue, D.P. Clark, and S.Z. Ali Reed-Sternberg-like cells in lymph node aspirates in the absence of Hodgkin's disease: pathologic significance and differential diagnosis Diagn Cytopathol 27 2002 335 339
20. M. Kojima, S. Nakamura, H. Itoh, Y. Yamane, S. Miyawaki, and N. Masawa Lymph node lesion in infectious mononucleosis showing geographic necrosis containing cytologically atypical B-cells. A case report Pathol Res Pract 200 2004 53 57
21. E. Maggio, A. van den Berg, A. Diepstra, J. Kluiver, L. Visser, and S. Poppema Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues Ann Oncol 13 2002 52 56
22. D. Aldinucci, D. Lorenzon, K. Olivo, B. Rapana, and V. Gattei Interactions between tissue fibroblasts in lymph nodes and Hodgkin/Reed- Sternberg cells Leuk Lymphoma 45 2004 1731 1739
23. A.B. Rickinson, and E. Kieff Epstein-Barr virus D. Knipe P.M. Howley 4th ed. Fields Virology vol. 2 2001 Lippincott Williams & Wilkins Philadelphia 2575 2627
24. P.G. Murray, and L.S. Young Epstein-Barr virus and oncogenesis: from latent genes to tumours Oncogene 22 2003 5108 5121
25. G. Khan, E.M. Miyashita, B. Yang, G.J. Babock, and D.A. Thorley-Lawson Is EBV persistence in vivo a model for B cell homeostasis? Immunity 2 1996 173 179
26. D.A. Thorley-Lawson, E.M. Miyashita, and G. Khan Epstein-Barr virus and the B cell: that's all it takes Trends Microbiol 4 1996 204 208
27. D.M. Burns, and D.H. Crawford Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease Blood Rev 18 2004 193 209
28. G. Khan, A. Lake, and L. Shield Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma Br J Haematol 129 2005 511 519
29. L.M. Weiss, L.A. Movahed, R.A. Warnke, and J. Sklar Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease N Engl J Med 320 1989 502 506
30. G. Khan, P.J. Coates, R.K. Gupta, H.O. Kangro, and G. Slavin Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells Am J Pathol 140 1992 757 762
31. G. Khan, A.J. Norton, and G. Slavin Epstein-Barr virus in Hodgkin disease. Relation to age and subtype Cancer 71 1993 3124 3129
32. S.L. Glaser, R.J. Lin, and S.L. Stewart Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data Int J Cancer 70 1997 375 382
33. A.A. Armstrong, F.E. Alexander, and R. Cartwright Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis Leukemia 12 1998 1272 1276
34. R.F. Jarrett, G.L. Stark, and J. White Impact of tumour Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classical Hodgkin lymphoma: a population-based study Blood 106 2005 2444 2451
35. G. Pallesen, S.J. Hamilton-Dutoit, M. Rowe, and L.S. Young Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease Lancet 337 1991 320 322
36. H. Herbst, F. Dallenbach, and M. Hummel Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells Proc Natl Acad Sci U S A 88 1991 4766 4770
37. D. Wang, D. Liebowitz, and E. Kieff An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells Cell 43 1985 831 840
38. A.G. Eliopoulos, M. Stack, and C.W. Dawson Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors Oncogene 14 1997 2899 2916
39. O. Gires, U. Zimber-Strobl, and R. Gonnella Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule EMBO J 16 1997 6131 6140
40. S.H. Kim, Y.K. Shin, and I.S. Lee Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype Blood 95 2000 294 300
41. R. Kuppers B cells under influence: Transformation of B-cells by Epstein-Barr virus Nat Rev Immunol 3 2003 801 812
42. H. Kanzler, R. Kuppers, M.L. Hansmann, and K. Rajewsky Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells J Exp Med 184 1996 1495 1505
43. K. Rajewsky Clonal selection and learning in the antibody system Nature 381 1996 751 758
44. K.P. Lam, R. Kuhn, and K. Rajewsky In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death Cell 90 1997 1073 1083
45. A. Ashkenazi, and V.M. Dixit Death receptors: signaling and modulation Science 281 1998 1305 1308
46. Y. Takahashi, H. Ohta, and T. Takemori Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire Immunity 14 2001 181 192
47. D. Re, A. Hofmann, J. Wolf, V. Diehl, and A. Staratschek-Jox Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95 Exp Hematol 28 2000 31 35
48. S. Mathas, A. Lietz, and I. Anagnostopoulos c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis J Exp Med 199 2004 1041 1052
49. M. Irmler, M. Thome, and M. Hahne Inhibition of death receptor signals by cellular FLIP Nature 388 1997 190 195
50. A. Hennino, M. Berard, P.H. Krammer, and T. Defrance FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis J Exp Med 193 2001 447 458
51. D. Re, R.K. Thomas, K. Behringer, and V. Diehl From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential Blood 105 2005 4553 4560
52. R.K. Thomas, A. Kallenborn, and C. Wickenhauser Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells Am J Pathol 160 2002 1521 1528
53. C. Messineo, M.H. Jamerson, and E. Hunter Gene expression by single Reed-Sternberg cells: pathways of apoptosis and activation Blood 91 1998 2443 2451
54. J. Cossman, C. Messineo, and A. Bagg Reed-Sternberg cell: survival in a hostile sea Lab Invest 78 1998 229 235
55. M. Hinz, P. Lemke, and I. Anagnostopoulos Nuclear factor κB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity J Exp Med 196 2002 605 617
56. M. Malec, M. Soderqvist, and A. Sirsjo Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma Haematologica 89 2004 679 685
57. R. Ravi, and A. Bedi NFκB in cancer-a friend turned foe Drug Res Update 7 2004 53 67
58. V. Diehl, H. Stein, M. Hummel, R. Zollinger, and J.M. Connors Hodgkin's lymphoma: Biology and treatment strategies for primary, refractory, and relapse disease Haematologica 1 2003 225 247
59. A. Zlotnik Chemokines in neoplastic progression Semin Cancer Biol 14 2004 181 185
60. U. Kapp, J. Wolf, and M. Hummel Hodgkin's lymphoma-derived tissue serially transplanted into severe combined immunodeficient mice Blood 82 1993 1247 1256
61. M. Samoszuk, and L. Nansen Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia Blood 75 1990 13 16
62. H. Hanamoto, T. Nakayama, and H. Miyazato Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells Am J Pathol 164 2004 997 1006
63. F. Jundt, I. Anagnostopoulos, and K. Bommert Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils Blood 94 1999 2065 2071
64. H.D. Foss, H. Herbst, and E. Oelmann Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases Br J Haematol 84 1993 627 635
65. O. Micheau, and J. Tschopp Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes Cell 114 2003 181 190
66. B.C. Barnhart, and M.E. Peter The TNF receptor 1: a split personality complex Cell 114 2003 148 150
67. A. van den Berg, L. Visser, and S. Poppema High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma Am J Pathol 154 1999 1685 1691
68. T.J. Schall, K. Bacon, K.J. Toy, and D.V. Goeddel Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES Nature 347 1990 669 671
69. A. Rot, M. Krieger, T. Brunner, S.C. Bischoff, T.J. Schall, and C.A. Dahinden RANTES and macrophage inflammatory protein 1 α induce the migration and activation of normal human eosinophil granulocytes J Exp Med 176 1992 1489 1495
70. N. Tedla, P. Palladinetti, D. Wakefield, and A. Lloyd Abundant expression of chemokines in malignant and infective human lymphadenopathies Cytokine 11 1999 531 540
71. M. Fischer, M. Juremalm, and N. Olsson Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue Int J Cancer 107 2003 197 201
72. M. Jucker, H. Abts, and W. Li Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease Blood 77 1991 2413 2418
73. H.D. Foss, M. Hummel, and S. Gottstein Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease Am J Pathol 146 1995 33 39
74. H.J. Gruss, M.A. Brach, H.G. Drexler, R. Bonifer, R.H. Mertelsmann, and F. Herrmann Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells Cancer Res 52 1992 3353 3360
75. H. Herbst, H.D. Foss, and J. Samol Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease Blood 87 1996 2918 2929
76. D.F. Dukers, L.H. Jaspars, and W. Vos Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease J Pathol 190 2000 143 149
77. K. Taga, H. Mostowski, and G. Tosato Human interleukin-10 can directly inhibit T-cell growth Blood 81 1993 2964 2971
78. C.C. Su, H.H. Chiu, C.C. Chang, J.C. Chen, and S.M. Hsu CD30 is involved in inhibition of T-cell proliferation by Hodgkin's Reed-Sternberg cells Cancer Res 64 2004 2148 2152
79. U. Kapp, W.C. Yeh, and B. Patterson Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells J Exp Med 189 1999 1939 1946
80. B.F. Skinnider, A.J. Elia, and R.D. Gascoyne Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma Blood 97 2001 250 255
81. K. Ohshima, M. Akaiwa, R. Umeshita, J. Suzumiya, K. Izuhara, and M. Kikuchi Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis Histopathology 38 2001 368 375
82. U.E. Hopken, H.D. Foss, and D. Meyer Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs Blood 99 2002 1109 1116
83. A. Muller, B. Homey, and H. Soto Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56
84. H.D. Foss, H. Herbst, S. Gottstein, G. Demel, I. Araujo, and H. Stein Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density Am J Pathol 148 1996 1229 1236
85. J. Schwaller, A. Tobler, and G. Niklaus Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders Blood 85 1995 2182 2188
86. M. Kadin, J. Butmarc, A. Elovic, and D. Wong Eosinophils are the major source of transforming growth factor-β 1 in nodular sclerosing Hodgkin's disease Am J Pathol 142 1993 11 16
87. S.R. Newcom, and L. Gu Transforming growth factor β 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease J Clin Pathol 48 1995 160 163
88. J.H. Kehrl, L.M. Wakefield, and A.B. Roberts Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth J Exp Med 163 1986 1037 1050
89. S.M. Hsu, J. Lin, S.S. Xie, P.L. Hsu, and S. Rich Abundant expression of transforming growth factor-β 1 and -β 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease Hum Pathol 24 1993 249 255
90. M.A. Huber, N. Azoitei, and B. Baumann NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression J Clin Invest 114 2004 569 581
91. P. Viatour, M.P. Merville, V. Bours, and A. Chariot Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation Trends Biochem Sci 30 2005 43 52
92. K.M. Wood, M. Roff, and R.T. Hay Defective IκBα in Hodgkin cell lines with constitutively active NF-κB Oncogene 16 1998 2131 2139
93. E. Cabannes, G. Khan, F. Aillet, R.F. Jarrett, and R.T. Hay Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα Oncogene 18 1999 3063 3070
94. R. Horie, T. Watanabe, and Y. Morishita Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin-Reed-Sternberg cells Oncogene 21 2002 2493 2503
95. R. Kuppers, and M.L. Hansmann The Hodgkin and Reed/Sternberg cell Int J Biochem Cell Biol 37 2005 511 517
96. R.C. Bargou, F. Emmerich, and D. Krappmann Constitutive nuclear factor-κ B-Rel A activation is required for proliferation and survival of Hodgkin's disease tumor cells J Clin Invest 100 1997 2961 2969
97. J.A. Herrero, P. Mathew, and C.V. Paya LMP-1 activates NF-κ B by targeting the inhibitory molecule I κ B α J Virol 69 1995 2168 2174
98. M. Hinz, P. Loser, S. Mathas, D. Krappmann, B. Dorken, and C. Scheidereit Constitutive NF-κB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells Blood 97 2001 2798 2807
99. O. Devergne, E. Hatzivassiliou, and K. Izumi Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr Virus LMP1 domain important for B lymphocyte transformation: role in NF-κB activation Mol Cell Biol 16 1996 7098 7108
100. E.T. Chang, T. Zheng, and E.G. Weir Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study J Natl Cancer Inst 96 2004 305 315